BREMEN Eye Drops Versus Combigan for Open-angle Glaucoma or Intraocular Hypertension

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The purpose of this study is to evaluate the clinical efficacy of the BREMEN eye drops in the treatment of primary open-angle glaucoma or intraocular hypertension.
Epistemonikos ID: e55a4bdbe12f07b04a38b94d525197dfeffc715f
First added on: May 21, 2024